Advertisement

Relation Between Obesity and Survival in Patients Hospitalized for Pulmonary Arterial Hypertension (from a Nationwide Inpatient Sample Database 2003 to 2011)

      There have been numerous studies reporting lower mortality rates in obese patients with various cardiovascular disorders than in nonobese patients, a phenomenon known as the “obesity paradox.” Limited data exist regarding the effect of obesity on prognosis in patients with pulmonary arterial hypertension (PAH). We used the National Inpatient Sample database for years 2003 to 2011 to identify all patient hospitalizations aged ≥18 years with a primary diagnosis of PAH. Patients with a diagnosis of obesity were identified using Elixhauser co-morbidity measure provided in Nationwide Inpatient Sample database, based on International Classification of Diseases, Ninth Revision, Clinical Modification, codes and the diagnosis-related groups. Multivariable logistic regression was used to compare in-hospital mortality between obese and nonobese patients with PAH. Of the 18,450 patients with a primary diagnosis of PAH, 14.7% were obese. Obese patients with PAH were younger, more often women, and more often black compared with nonobese white patients. After risk adjustment for demographics, hospital characteristics, and baseline co-morbidities, obese patients with PAH had lower observed in-hospital mortality compared with nonobese patients with PAH (3.5% vs 8.1%; adjusted odds ratio 0.66, 95% confidence interval 0.51 to 0.85, p = 0.001). In conclusion, from a 9-year nationwide cohort of patients with PAH, we observed significantly lower risk-adjusted in-hospital mortality in obese patients compared with nonobese patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Poirier P.
        • Giles T.D.
        • Bray G.A.
        • Hong Y.
        • Stern J.S.
        • Pi-Sunyer F.X.
        • Eckel R.H.
        Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss.
        Arterioscler Thromb Vasc Biol. 2006; 26: 968-976
        • Lainscak M.
        • von Haehling S.
        • Doehner W.
        • Sarc I.
        • Jeric T.
        • Ziherl K.
        • Kosnik M.
        • Anker S.D.
        • Suskovic S.
        Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.
        J Cachexia Sarcopenia Muscle. 2011; 2: 81-86
        • Fonarow G.C.
        • Srikanthan P.
        • Costanzo M.R.
        • Cintron G.B.
        • Lopatin M.
        • Committee A.S.A.
        Investigators. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry.
        Am Heart J. 2007; 153: 74-81
        • Chittal P.
        • Babu A.S.
        • Lavie C.J.
        Obesity paradox: does fat alter outcomes in chronic obstructive pulmonary disease?.
        COPD. 2015; 12: 14-18
        • Lavie C.J.
        • Sharma A.
        • Alpert M.A.
        • De Schutter A.
        • Lopez-Jimenez F.
        • Milani R.V.
        • Ventura H.O.
        Update on obesity and obesity paradox in heart failure.
        Prog Cardiovasc Dis. 2016; 58: 393-400
        • Uretsky S.
        • Messerli F.H.
        • Bangalore S.
        • Champion A.
        • Cooper-Dehoff R.M.
        • Zhou Q.
        • Pepine C.J.
        Obesity paradox in patients with hypertension and coronary artery disease.
        Am J Med. 2007; 120: 863-870
        • Poms A.D.
        • Turner M.
        • Farber H.W.
        • Meltzer L.A.
        • McGoon M.D.
        Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis.
        Chest. 2013; 144: 169-176
        • Benza R.L.
        • Gomberg-Maitland M.
        • Naeije R.
        • Arneson C.P.
        • Lang I.M.
        Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.
        J Heart Lung Transplant. 2011; 30: 982-989
        • Zafrir B.
        • Adir Y.
        • Shehadeh W.
        • Shteinberg M.
        • Salman N.
        • Amir O.
        The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the “obesity paradox”.
        Respir Med. 2013; 107: 139-146
        • Robbins I.M.
        • Moore T.M.
        • Blaisdell C.J.
        • Abman S.H.
        Improving outcomes for pulmonary vascular disease.
        Am J Respir Crit Care Med. 2012; 185: 1015-1020
      1. Healthcare Cost and Utilization Project (HCUP). Overview of the National (nationwide) Inpatient Sample (NIS), Rockville. Available at: https://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed on January 10, 2016.

        • Anand V.
        • Roy S.S.
        • Archer S.L.
        • Weir E.K.
        • Garg S.K.
        • Duval S.
        • Thenappan T.
        Trends and outcomes of pulmonary arterial hypertension-related hospitalizations in the United States: analysis of the nationwide inpatient sample database from 2001 through 2012.
        JAMA Cardiol. 2016; 1: 1021-1029
        • Elixhauser A.
        • Steiner C.
        • Harris D.R.
        • Coffey R.M.
        Comorbidity measures for use with administrative data.
        Med Care. 1998; 36: 8-27
        • Alpert M.A.
        Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome.
        Am J Med Sci. 2001; 321: 225-236
        • Vasan R.S.
        Cardiac function and obesity.
        Heart. 2003; 89: 1127-1129
        • Alpert M.A.
        • Omran J.
        • Mehra A.
        • Ardhanari S.
        Impact of obesity and weight loss on cardiac performance and morphology in adults.
        Prog Cardiovasc Dis. 2014; 56: 391-400
        • Oktay A.A.
        • Lavie C.J.
        • Milani R.V.
        • Ventura H.O.
        • Gilliland Y.E.
        • Shah S.
        • Cash M.E.
        Current perspectives on left ventricular geometry in systemic hypertension.
        Prog Cardiovasc Dis. 2016; 59: 235-246
        • Diong C.
        • Jones P.P.
        • Tsuchimochi H.
        • Gray E.A.
        • Hughes G.
        • Inagaki T.
        • Bussey C.T.
        • Fujii Y.
        • Umetani K.
        • Shirai M.
        • Schwenke D.O.
        Sympathetic hyper-excitation in obesity and pulmonary hypertension: physiological relevance to the ‘obesity paradox’.
        Int J Obes (Lond). 2016; 40: 938-946
        • Lainscak M.
        • von Haehling S.
        • Doehner W.
        • Anker S.D.
        The obesity paradox in chronic disease: facts and numbers.
        J Cachexia Sarcopenia Muscle. 2012; 3: 1-4
        • Parto P.
        • Lavie C.J.
        • Arena R.
        • Bond S.
        • Popovic D.
        • Ventura H.O.
        Body habitus in heart failure: understanding the mechanisms and clinical significance of the obesity paradox.
        Future Cardiol. 2016; 12: 639-653
        • Groth A.
        • Vrugt B.
        • Brock M.
        • Speich R.
        • Ulrich S.
        • Huber L.C.
        Inflammatory cytokines in pulmonary hypertension.
        Respir Res. 2014; 15: 47
        • Horwich T.B.
        • Fonarow G.C.
        • Hamilton M.A.
        • MacLellan W.R.
        • Woo M.A.
        • Tillisch J.H.
        The relationship between obesity and mortality in patients with heart failure.
        J Am Coll Cardiol. 2001; 38: 789-795
        • Lavie C.J.
        • Alpert M.A.
        • Arena R.
        • Mehra M.R.
        • Milani R.V.
        • Ventura H.O.
        Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure.
        JACC Heart Fail. 2013; 1: 93-102
        • Bastien M.
        • Poirier P.
        • Lemieux I.
        • Despres J.P.
        Overview of epidemiology and contribution of obesity to cardiovascular disease.
        Prog Cardiovasc Dis. 2014; 56: 369-381
        • Taraseviciute A.
        • Voelkel N.F.
        Severe pulmonary hypertension in postmenopausal obese women.
        Eur J Med Res. 2006; 11: 198-202
        • Badesch D.B.
        • Raskob G.E.
        • Elliott C.G.
        • Krichman A.M.
        • Farber H.W.
        • Frost A.E.
        • Barst R.J.
        • Benza R.L.
        • Liou T.G.
        • Turner M.
        • Giles S.
        • Feldkircher K.
        • Miller D.P.
        • McGoon M.D.
        Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.
        Chest. 2010; 137: 376-387
        • Al Kazzi E.S.
        • Lau B.
        • Li T.
        • Schneider E.B.
        • Makary M.A.
        • Hutfless S.
        Differences in the prevalence of obesity, smoking and alcohol in the United States nationwide inpatient sample and the Behavioral Risk Factor Surveillance System.
        PLoS One. 2015; 10: e0140165
        • Arena R.
        • Lavie C.J.
        • Borghi-Silva A.
        • Daugherty J.
        • Bond S.
        • Phillips S.A.
        • Guazzi M.
        Exercise training in group 2 pulmonary hypertension: which intensity and what modality.
        Prog Cardiovasc Dis. 2016; 59: 87-94
        • Lavie C.J.
        • De Schutter A.
        • Parto P.
        • Jahangir E.
        • Kokkinos P.
        • Ortega F.B.
        • Arena R.
        • Milani R.V.
        Obesity and prevalence of cardiovascular diseases and prognosis-the obesity paradox updated.
        Prog Cardiovasc Dis. 2016; 58: 537-547
        • Lavie C.J.
        • McAuley P.A.
        • Church T.S.
        • Milani R.V.
        • Blair S.N.
        Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox.
        J Am Coll Cardiol. 2014; 63: 1345-1354